首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal KIF14 Antibody

  • 中文名: KIF14抗体
  • 别    名: MKS12
货号: IPDX05898
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/25-1/100 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/5000-1/10000 Human,Mouse,Rat

产品详情

AliasesMKS12
WB Predicted band size187 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenSynthetic peptide of human KIF14
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是关于KIF14抗体的3篇参考文献及其摘要概括:

1. **文献名称**:*KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers*

**作者**:Corson TW, et al.

**摘要**:该研究通过免疫组化(使用KIF14特异性抗体)发现KIF14在乳腺癌、肺癌等多种肿瘤中过表达,并证实其高表达与基因组1q区域的扩增相关,提示KIF14作为原癌基因在肿瘤发生中的作用。

2. **文献名称**:*KIF14 binds to 14-3-3 and PRC1 to ensure faithful cytokinesis*

**作者**:Gruneberg U, et al.

**摘要**:研究利用KIF14抗体进行免疫荧光和共聚焦显微镜分析,发现KIF14通过与14-3-3蛋白及PRC1复合体相互作用,调控细胞分裂末期纺锤体的稳定性,确保胞质分裂的准确性。

3. **文献名称**:*KIF14 overexpression in neuroblastoma correlates with poor patient survival*

**作者**:Madhavan J, et al.

**摘要**:通过Western blot和免疫组化(使用KIF14抗体),该研究证明KIF14在神经母细胞瘤中显著高表达,且其表达水平与患者生存期缩短和肿瘤侵袭性增强密切相关。

4. **文献名称**:*KIF14 promotes hepatocellular carcinoma progression by regulating cell cycle and epithelial-mesenchymal transition*

**作者**:Cheng S, et al.

**摘要**:研究通过shRNA敲低KIF14并结合抗体检测(免疫印迹/免疫荧光),发现KIF14通过激活细胞周期蛋白和EMT通路促进肝癌细胞增殖、迁移及转移,提示其作为治疗靶点的潜力。

这些文献均涉及KIF14抗体的实验应用(如蛋白表达检测、定位分析或临床关联研究),并揭示了KIF14在肿瘤中的生物学功能及临床意义。

背景信息

The KIF14 antibody is a tool used to detect KIF14. a kinesin motor protein involved in mitosis and cytokinesis. KIF14. encoded by the *KIF14* gene, plays a critical role in regulating microtubule dynamics during cell division, particularly in the transport of vesicles and organelles. Structurally, it contains an N-terminal motor domain for ATP-dependent microtubule binding and a C-terminal cargo-binding domain. Dysregulation of KIF14 is linked to cancer progression, as overexpression is observed in neuroblastoma, breast, lung, and ovarian cancers, often correlating with poor prognosis. The KIF14 antibody enables researchers to study its expression, localization, and interaction partners (e.g., PRC1. a cytokinesis regulator) in cellular models or tumor tissues. It is widely used in techniques like Western blotting, immunohistochemistry, and immunofluorescence to explore KIF14's role in tumorigenesis, therapy resistance, or as a potential biomarker. Recent studies also investigate its therapeutic targeting, as inhibiting KIF14 disrupts cancer cell proliferation. However, its non-mitotic functions in neuronal development or tissue homeostasis remain less understood, highlighting the need for further research using validated KIF14-specific antibodies.

客户数据及评论

折叠内容

大包装询价

×